Emerging Cell Therapies:
Realizing the Vision of NextGen Cell Therapeutics
January 25-27, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change
Preferred
(EDT)
Happening
Any Time
Content
Dates
Tracks
Speakers
Rooms
Showing results 1 - 9 of 9
Monday, January 25, 2021
Welcoming Remarks and Keynote Address
10:00 AM - 10:40 AM EST
Monday, January 25, 2021Room: V300 Guy Coombes Organizer
Kole Roybal, PhD
University of California, San Francisco
Keynote
David Baker, PhD
University of Washington
Welcoming Remarks and Keynote Address
Computational Protein Design for Next-Generation Cellular Therapeutics
10:00 AM - 10:40 AM EST
Monday, January 25, 2021Room: V300 Guy Coombes Keynote
David Baker, PhD
University of Washington
Welcoming Remarks and Keynote Address
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
10:40 AM - 1:00 PM EST
Monday, January 25, 2021Room: Multi Tech Session Co-Chairs
Kole Roybal, PhD
University of California, San Francisco
Yvonne Chen, PhD
University of California, Los Angeles
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
Next-Generation CART Approaches Exploiting Natural Killer Receptor Targeting
10:40 AM - 11:05 AM EST
Monday, January 25, 2021Room: V200 Ronney Laws Speaker
David Gilham, PhD
Celyad
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
[NOT AVAILABLE ON DEMAND] New T Cell Therapeutics
11:05 AM - 11:30 AM EST
Monday, January 25, 2021Room: V200 Ronney Laws Speaker
Marcela Maus, MD, PhD
Harvard Medical School
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
Coffee Break
11:30 AM - 11:45 AM EST
Monday, January 25, 2021Coffee Break
CAR T Cells for the Treatment of Brain Malignancies
11:45 AM - 12:10 PM EST
Monday, January 25, 2021Speaker
Christine Brown, PhD
Beckman Research Institute, City of Hope
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
Manufacturing Next-Generation Cellular Therapies
12:10 PM - 12:35 PM EST
Monday, January 25, 2021Speaker
Isabelle Riviere, PhD
Memorial Sloan-Kettering Cancer Center
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
Allogeneic CAR T Therapy for the Treatment of Cancer
12:35 PM - 1:00 PM EST
Monday, January 25, 2021Speaker
Barbra Sasu, PhD
Allogene Therapeutics
The Current State of Cellular Therapies for Cancer: Lessons from the Clinic
Career Roundtable
2:30 PM - 3:30 PM EST
Monday, January 25, 2021Panelists
Darrell Irvine, PhD
Massachusetts Institute of Technology
Marcela Maus, MD, PhD
Harvard Medical School
Jane Grogan, PhD
Arsenal Biosciences
Career Roundtable
New Approaches for Programming Cellular Therapeutics
5:00 PM - 8:00 PM EST
Monday, January 25, 2021Room: Multi Tech Session Co-Chairs
Alex Marson, MD, PhD
University of California, San Francisco
Ahmad Khalil, PhD
Boston University
New Approaches for Programming Cellular Therapeutics
Reprogramming Immune Cell Therapeutics with Non-Viral Gene Editing Approaches
5:00 PM - 5:25 PM EST
Monday, January 25, 2021Room: V200 Ronney Laws Speaker
Alex Marson, MD, PhD
University of California, San Francisco
New Approaches for Programming Cellular Therapeutics
Engineered Cytokines for Cancer Immunotherapy
5:25 PM - 5:50 PM EST
Monday, January 25, 2021Room: V200 Ronney Laws Speaker
Aaron Ring, MD, PhD
Yale School of Medicine
New Approaches for Programming Cellular Therapeutics
Expanding the Functional Capacity of Therapeutic Immune Cells
5:50 PM - 6:15 PM EST
Monday, January 25, 2021Room: V200 Ronney Laws Speaker
Dario Campana, MD, PhD
National University of Singapore
New Approaches for Programming Cellular Therapeutics
Design of Eukaryotic Gene Regulatory Circuits
6:15 PM - 6:40 PM EST
Monday, January 25, 2021Room: V200 Ronney Laws Speaker
Ahmad Khalil, PhD
Boston University
New Approaches for Programming Cellular Therapeutics
Coffee Break
6:40 PM - 6:45 PM EST
Monday, January 25, 2021Coffee Break
Short Talk: Elimination of Mouse B Cells by Non-Virally Engineered CAR19 Knock-In T Cells
6:45 PM - 7:00 PM EST
Monday, January 25, 2021Speaker
Romina Marone, PhD
University of Basel, DBM
New Approaches for Programming Cellular Therapeutics
Short Talk: Engineering B Cells in-vivo Elicits Potent Cellular and Serological Responses in Mice
7:00 PM - 7:15 PM EST
Monday, January 25, 2021Speaker
Alessio Nahmad
Tel Aviv University
New Approaches for Programming Cellular Therapeutics
Short Talk: Efficient Gene Knockout in Primary Myeloid Cells by Non-Viral Delivery of CRISPR-Cas9
7:15 PM - 7:30 PM EST
Monday, January 25, 2021Speaker
Aditya Murthy, PhD
Genentech, Inc.
New Approaches for Programming Cellular Therapeutics
Short Talk: Microfluidic Cell Squeezing Enables the Generation of Novel Cell Therapies for Diverse Clinical Applications
7:30 PM - 7:45 PM EST
Monday, January 25, 2021Speaker
Jonathan Gilbert, PhD
SQZ Biotechnology
New Approaches for Programming Cellular Therapeutics
Short Talk: Using Data-Driven Approaches to Develop Engineered Cell Therapies
7:45 PM - 8:00 PM EST
Monday, January 25, 2021Speaker
Owen Rackham, PhD
Duke-NUS
New Approaches for Programming Cellular Therapeutics
Tuesday, January 26, 2021
Next-Generation Cellular Therapeutics for Cancer
10:00 AM - 1:00 PM EST
Tuesday, January 26, 2021Room: Multi Tech Session Co-Chairs
Yvonne Chen, PhD
University of California, Los Angeles
Kole Roybal, PhD
University of California, San Francisco
Next-Generation Cellular Therapeutics for Cancer
[NOT AVAILABLE ON DEMAND] Enhancing T-Cell Therapies by Rational Biomolecular Engineering
10:00 AM - 10:25 AM EST
Tuesday, January 26, 2021Room: V200 Ronney Laws Speaker
Yvonne Chen, PhD
University of California, Los Angeles
Next-Generation Cellular Therapeutics for Cancer
T Cell Therapies with Engineered Control Systems
10:25 AM - 10:50 AM EST
Tuesday, January 26, 2021Room: V200 Ronney Laws Speaker
Martin Pule, MD
University College London
Next-Generation Cellular Therapeutics for Cancer
Control and Customization of Immune Cell Therapies for Cancer
10:50 AM - 11:15 AM EST
Tuesday, January 26, 2021Room: V200 Ronney Laws Speaker
Kole Roybal, PhD
University of California, San Francisco
Next-Generation Cellular Therapeutics for Cancer
Development of Next-Generation T Cell Therapies
11:15 AM - 11:40 AM EST
Tuesday, January 26, 2021Room: V200 Ronney Laws Speaker
Jane Grogan, PhD
Arsenal Biosciences
Next-Generation Cellular Therapeutics for Cancer
Coffee Break
11:40 AM - 12:05 PM EST
Tuesday, January 26, 2021Coffee Break
Synthetic Biology Tools to Stimulate Anti-Tumor Immunity
12:05 PM - 12:30 PM EST
Tuesday, January 26, 2021Speaker
Timothy Lu, MD, PhD
Massachusetts Institute of Technology
Next-Generation Cellular Therapeutics for Cancer
Short Talk: Mechanisms of Adoptive T Cell Micropharmacies
12:30 PM - 12:45 PM EST
Tuesday, January 26, 2021Speaker
Christopher Bourne
Memorial Sloan Kettering Cancer Center
Next-Generation Cellular Therapeutics for Cancer
Short Talk: T Cell Circuits that Sense Antigen Density with an Ultrasensitive Threshold
12:45 PM - 1:00 PM EST
Tuesday, January 26, 2021Speaker
Rogelio Hernandez-Lopez, PhD
University of California, San Francisco
Next-Generation Cellular Therapeutics for Cancer
Meet the Editors Roundtable
1:30 PM - 2:30 PM EST
Tuesday, January 26, 2021Panelists
Meet the Editors Roundtable
Beyond Effector T Cell Therapeutics
5:00 PM - 8:00 PM EST
Tuesday, January 26, 2021Room: Multi Tech Session Co-Chairs
Saar Gill, PhD
University of Pennsylvania
Megan Levings, PhD
University of British Columbia
Beyond Effector T Cell Therapeutics
Engineered Macrophage Therapeutics
5:00 PM - 5:25 PM EST
Tuesday, January 26, 2021Room: V300 Guy Coombes Speaker
Saar Gill, PhD
University of Pennsylvania
Beyond Effector T Cell Therapeutics
NK Cell Therapies for Cancer
5:25 PM - 5:50 PM EST
Tuesday, January 26, 2021Room: V300 Guy Coombes Speaker
Dan Kaufman, MD
University of California, San Diego
Beyond Effector T Cell Therapeutics
Programming Bacteria as a Cancer Therapy
5:50 PM - 6:15 PM EST
Tuesday, January 26, 2021Room: V300 Guy Coombes Speaker
Tal Danino, PhD
Columbia University
Beyond Effector T Cell Therapeutics
Coffee Break
6:15 PM - 6:40 PM EST
Tuesday, January 26, 2021Coffee Break
NextGen Treg Therapies
6:40 PM - 7:05 PM EST
Tuesday, January 26, 2021Speaker
Megan Levings, PhD
University of British Columbia
Beyond Effector T Cell Therapeutics
Synthetic Biology Tools for the Development of Engineered Stem Cell Therapeutics
7:05 PM - 7:30 PM EST
Tuesday, January 26, 2021Speaker
Tara Deans, PhD
University of Utah
Beyond Effector T Cell Therapeutics
Short Talk: Engraftment of Gene-Engineered Human Plasma Cells in Humanized Mice Shows Early Promise for the Feasibility of Novel Plasma Cell-Based Therapies
7:30 PM - 7:45 PM EST
Tuesday, January 26, 2021Speaker
Tyler Hill, BS
University of Washington
Beyond Effector T Cell Therapeutics
Wednesday, January 27, 2021
Engineering Materials for Cellular Therapeutics
10:00 AM - 1:00 PM EST
Wednesday, January 27, 2021Room: Multi Tech Session Co-Chairs
Darrell Irvine, PhD
Massachusetts Institute of Technology
Tatiana Segura, PhD
Duke University
Engineering Materials for Cellular Therapeutics
Synthetic mRNA Nanocarriers for the in situ Programming of Disease-Specific Immune Cells
10:00 AM - 10:25 AM EST
Wednesday, January 27, 2021Room: V300 Guy Coombes Speaker
Matthias Stephan, PhD
Fred Hutchinson Cancer Research Center
Engineering Materials for Cellular Therapeutics
Endogenous Immunity Primed by Vaccine-Boosted CAR T Cell Therapy
10:25 AM - 10:50 AM EST
Wednesday, January 27, 2021Room: V300 Guy Coombes Speaker
Darrell Irvine, PhD
Massachusetts Institute of Technology
Engineering Materials for Cellular Therapeutics
Biomaterials for Tissue Repair and Regulation of Inflammation
10:50 AM - 11:15 AM EST
Wednesday, January 27, 2021Room: V300 Guy Coombes Speaker
Tatiana Segura, PhD
Duke University
Engineering Materials for Cellular Therapeutics
Coffee Break
11:15 AM - 11:35 AM EST
Wednesday, January 27, 2021Coffee Break
Artificial APCs to Manufacture and Boost T Cell Therapies
11:35 AM - 12:00 PM EST
Wednesday, January 27, 2021Speaker
David Mooney, PhD
Harvard University
Engineering Materials for Cellular Therapeutics
Short Talk: High-Aspect Ratio Nano-Structures for Efficient, Minimally Perturbative and Transgene-Free Immuno-Transfection
12:00 PM - 12:15 PM EST
Wednesday, January 27, 2021Speaker
Andy Tay, PhD
National University of Singapore
Engineering Materials for Cellular Therapeutics
Short Talk: Implantable Cell Therapy Platform With In Situ Pre-Vascularization and Localized Immunosuppression for Allogeneic Cell Transplantation
12:15 PM - 12:30 PM EST
Wednesday, January 27, 2021Speaker
Jesus Paez Mayorga, BS
Houston Methodist Hospital
Engineering Materials for Cellular Therapeutics
Short Talk: Dual Targeting of Cancer and Suppressive Myeloid Cells by Tumor-Redirected iNKT Cells and Antigen-Carrying Microparticles
12:30 PM - 12:45 PM EST
Wednesday, January 27, 2021Speaker
Gloria Delfanti, PhD
San Raffaele Scientific Institute
Engineering Materials for Cellular Therapeutics
Short Talk: Generalizable Computational Approach to Design Chemically Controlled Protein Switches with Multi-Logics for Cell-Based Therapeutics
12:45 PM - 1:00 PM EST
Wednesday, January 27, 2021Speaker
Sailan Shui, M.S.
École polytechnique fédérale de Lausanne
Engineering Materials for Cellular Therapeutics
Immune Cell Biology: Implications for Cellular Immunotherapy
5:00 PM - 8:00 PM EST
Wednesday, January 27, 2021Room: Multi Tech Session Co-Chairs
Miriam Merad, MD, PhD
Mount Sinai School of Medicine
Andrea Schietinger, PhD
Memorial Sloan Kettering Cancer Center
Immune Cell Biology: Implications for Cellular Immunotherapy
Myeloid Cell Contribution to Tumor Lesion Composition and Outcome
5:00 PM - 5:25 PM EST
Wednesday, January 27, 2021Speaker
Miriam Merad, MD, PhD
Mount Sinai School of Medicine
Immune Cell Biology: Implications for Cellular Immunotherapy
Regulation of T Cell Function in Tumors
5:25 PM - 5:50 PM EST
Wednesday, January 27, 2021Speaker
Andrea Schietinger, PhD
Memorial Sloan Kettering Cancer Center
Immune Cell Biology: Implications for Cellular Immunotherapy
NK Cells in Health and Disease
5:50 PM - 6:15 PM EST
Wednesday, January 27, 2021Speaker
Joseph Sun, PhD
Memorial Sloan Kettering Cancer Center
Immune Cell Biology: Implications for Cellular Immunotherapy
Coffee Break
6:15 PM - 6:45 PM EST
Wednesday, January 27, 2021Coffee Break
Short Talk: Disrupting Enhancers within the Core Epigenetic Program of Exhaustion Improves CD8+ T Cell Responses and Enhances Tumor Control
6:45 PM - 7:00 PM EST
Wednesday, January 27, 2021Room: V200 Ronney Laws Speaker
Debattama Sen, PhD
Massachusetts General Hospital
Immune Cell Biology: Implications for Cellular Immunotherapy
Short Talk: Mapping Cellular Interactions between Cancer and Normal Cells via Synthetic Notch Ligand/Receptor Pairs
7:00 PM - 7:15 PM EST
Wednesday, January 27, 2021Room: V200 Ronney Laws Speaker
Baris Avsaroglu
University of California, San Francisco
Immune Cell Biology: Implications for Cellular Immunotherapy
Short Talk: Unbiased Design of Engineered T Cell Therapies Using Functional CRISPR/Cas9 Screens
7:15 PM - 7:30 PM EST
Wednesday, January 27, 2021Room: V200 Ronney Laws Speaker
Micah Benson, PhD
KSQ Therapeutics
Immune Cell Biology: Implications for Cellular Immunotherapy
Short Talk: Uncovering the Cell-Type Specificity in Human T1D Immune Activation Using iPSC-beta Cells
7:30 PM - 7:45 PM EST
Wednesday, January 27, 2021Room: V200 Ronney Laws Speaker
Nayara Leite, PhD
Harvard
Immune Cell Biology: Implications for Cellular Immunotherapy
